Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Open-Label, Multicenter Study to Evaluate the Long-Term Safety of Sculptra®Aesthetic in Immuno-Competent Subjects Stratified by Fitzpatrick Skin Type I-VI)

NCT02425943 is registered in ClinicalTrials.gov with Galderma R&D as lead sponsor.

NCT NCT02425943
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02425943 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Open-Label, Multicenter Study to Evaluate the Long-Term Safety of Sculptra®Aesthetic in Immuno-Competent Subjects Stratified by Fitzpatrick Skin Type I-VI)
Lead sponsor
Galderma R&D
Phase
Phase 4
Overall status
Completed
Start date
May 21, 2015
Completion date
May 28, 2021
Enrollment
867 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

nasolabial fold contour deficiencies, wrinkles